Susan Wyllie - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Susan Wyllie

Showing results (91-100 of 94) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 94 results.

Science Translational Medicine|December 13, 2023

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.

ACS Infectious Diseases|December 7, 2019

Setting Our Sights on Infectious DiseasesManu De Rycker, David Horn, Bree Aldridge, et al.

Nucleic Acids Research|October 11, 2014

TrypanoCyc: a community-led biochemical pathways database for Trypanosoma bruceiSanu Shameer, Flora J Logan-Klumpler, Florence Vinson, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.

Pageof 10

Search research articles

Showing results (91-100 of 94) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 94 results.

Science Translational Medicine|December 13, 2023

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.

ACS Infectious Diseases|December 7, 2019

Setting Our Sights on Infectious DiseasesManu De Rycker, David Horn, Bree Aldridge, et al.

Nucleic Acids Research|October 11, 2014

TrypanoCyc: a community-led biochemical pathways database for Trypanosoma bruceiSanu Shameer, Flora J Logan-Klumpler, Florence Vinson, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.

Pageof 10